LATEST
Fri, Oct 9, 2026
Loading weather...
Markets

Johnson & Johnson Reports Sustained Two-Year ICOTYDE Results In Plaque Psoriasis

(RTTNews) - Johnson & Johnson (JNJ), a healthcare company focused on innovative medicines and medical technologies, repo...

(RTTNews) - Johnson & Johnson (JNJ), a healthcare company focused on innovative medicines and medical technologies, reported two-year results from the Phase 3 ICONIC-LEAD study of ICOTYDE (icotrokinra) in adults and adolescents aged 12 years and older with moderate-to-severe plaq

SOURCE: Nasdaq
ORIGINAL REPORT: Click here
DHALLO EDITORIAL STATUS: Aggregated & reviewed
Have feedback on this article?Report error or suggestion

Read More from Markets

Relief rally in Indian stock market; biggest weekly losing streak in 25 years snapped: What's next for Sensex, Nifty?

Indian equities ended the week higher after Friday’s rally helped the Nifty gain...

Read Article »

₹3 cr per month salary? Meet India's 'highest-paid' bank CEO - ICICI veteran and HDFC's Anup Bagchi

HDFC Bank has reportedly proposed annual pay of up to ₹35.90 crore for incoming ...

Read Article »

Airtel Money IPO: London’s biggest listing in 5 years makes debut — Check how shares performed post-listing

Airtel Money debuted on the London Stock Exchange in its largest IPO in five yea...

Read Article »
Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.